Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Lung Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 186 articles: HTML format

Single Articles

April 2008
1. HANN CL , Daniel VC, Sugar EA, Dobromilskaya I, et al
   Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.
   Cancer Res. 2008;68:2321-8.
   PubMed     Related articles    Abstract available
   
   
   
2. VICENT S , Luis-Ravelo D, Anton I, Garcia-Tunon I, et al
   A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism.
   Cancer Res. 2008;68:2275-85.
   PubMed     Related articles    Abstract available
   
   
   
3. YATABE Y , Takahashi T, Mitsudomi T
   Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer.
   Cancer Res. 2008;68:2106-11.
   PubMed     Related articles    Abstract available
   
   
   March 2008
4. BULK E , Hascher A, Liersch R, Mesters RM, et al
   Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.
   Cancer Res. 2008;68:1896-904.
   PubMed     Related articles    Abstract available
   
   
   
5. TESSEMA M , Willink R, Do K, Yu YY, et al
   Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.
   Cancer Res. 2008;68:1707-14.
   PubMed     Related articles    Abstract available
   
   
   
6. OSADA H , Tomida S, Yatabe Y, Tatematsu Y, et al
   Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.
   Cancer Res. 2008;68:1647-55.
   PubMed     Related articles    Abstract available
   
   
   
7. LAKSHMAN M , Xu L, Ananthanarayanan V, Cooper J, et al
   Dietary genistein inhibits metastasis of human prostate cancer in mice.
   Cancer Res. 2008;68:2024-32.
   PubMed     Related articles    Abstract available
   
   
   
8. PARK JM , Terabe M, Steel JC, Forni G, et al
   Therapy of advanced established murine breast cancer with a recombinant adenoviral ErbB-2/neu vaccine.
   Cancer Res. 2008;68:1979-87.
   PubMed     Related articles    Abstract available
   
   
   
9. BIERIE B , Stover DG, Abel TW, Chytil A, et al
   Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
   Cancer Res. 2008;68:1809-19.
   PubMed     Related articles    Abstract available
   
   
   
10. DE NIGRIS F , Rossiello R, Schiano C, Arra C, et al
    Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis.
    Cancer Res. 2008;68:1797-808.
    PubMed     Related articles    Abstract available
    
    
    
11. RAMALINGAM A , Duhadaway JB, Sutanto-Ward E, Wang Y, et al
    Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging.
    Cancer Res. 2008;68:1683-90.
    PubMed     Related articles    Abstract available
    
    
    
12. SUMITOMO M , Koizumi F, Asano T, Horiguchi A, et al
    Novel SN-38-incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression.
    Cancer Res. 2008;68:1631-5.
    PubMed     Related articles    Abstract available
    
    
    
13. OHTA T , Iijima K, Miyamoto M, Nakahara I, et al
    Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.
    Cancer Res. 2008;68:1303-9.
    PubMed     Related articles    Abstract available
    
    
    February 2008
14. IWANAGA K , Yang Y, Raso MG, Ma L, et al
    Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.
    Cancer Res. 2008;68:1119-27.
    PubMed     Related articles    Abstract available
    
    
    
15. LUXEN S , Belinsky SA, Knaus UG
    Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer.
    Cancer Res. 2008;68:1037-45.
    PubMed     Related articles    Abstract available
    
    
    
16. AGGARWAL S , Kim SW, Ryu SH, Chung WC, et al
    Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein.
    Cancer Res. 2008;68:981-8.
    PubMed     Related articles    Abstract available
    
    
    
17. DIFEO A , Feld L, Rodriguez E, Wang C, et al
    A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.
    Cancer Res. 2008;68:965-70.
    PubMed     Related articles    Abstract available
    
    
    
18. ZHANG S , Schafer-Hales K, Khuri FR, Zhou W, et al
    The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity.
    Cancer Res. 2008;68:740-8.
    PubMed     Related articles    Abstract available
    
    
    January 2008
19. MEMMOTT RM , Gills JJ, Hollingshead M, Powers MC, et al
    Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Cancer Res. 2008;68:580-8.
    PubMed     Related articles    Abstract available
    
    
    
20. SAWAI A , Chandarlapaty S, Greulich H, Gonen M, et al
    Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel.
    Cancer Res. 2008;68:589-96.
    PubMed     Related articles    Abstract available
    
    
    
21. GILMER TM , Cable L, Alligood K, Rusnak D, et al
    Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib.
    Cancer Res. 2008;68:571-9.
    PubMed     Related articles    Abstract available
    
    
    
22. SARFARAZ S , Adhami VM, Syed DN, Afaq F, et al
    Cannabinoids for cancer treatment: progress and promise.
    Cancer Res. 2008;68:339-42.
    PubMed     Related articles    Abstract available
    
    
    
23. JAGADEESWARAN R , Surawska H, Krishnaswamy S, Janamanchi V, et al
    Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
    Cancer Res. 2008;68:132-42.
    PubMed     Related articles    Abstract available
    
    
    
24. KONG X , Wang X, Xu W, Behera S, et al
    Natriuretic peptide receptor a as a novel anticancer target.
    Cancer Res. 2008;68:249-56.
    PubMed     Related articles    Abstract available
    
    
    
25. AMANN M , Brischwein K, Lutterbuese P, Parr L, et al
    Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3.
    Cancer Res. 2008;68:143-51.
    PubMed     Related articles    Abstract available
    
    
    
26. GURUMURTHY S , Hezel AF, Berger JH, Bosenberg MW, et al
    LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.
    Cancer Res. 2008;68:55-63.
    PubMed     Related articles    Abstract available
    
    
    
27. STEARMAN RS , Dwyer-Nield L, Grady MC, Malkinson AM, et al
    A macrophage gene expression signature defines a field effect in the lung tumor microenvironment.
    Cancer Res. 2008;68:34-43.
    PubMed     Related articles    Abstract available
    
    
    December 2007
28. WHYTE L , Huang YY, Torres K, Mehta RG, et al
    Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses.
    Cancer Res. 2007;67:12007-17.
    PubMed     Related articles    Abstract available
    
    
    
29. PEREIRA-FACA SR , Kuick R, Puravs E, Zhang Q, et al
    Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
    Cancer Res. 2007;67:12000-6.
    PubMed     Related articles    Abstract available
    
    
    
30. ENGELMAN JA , Zejnullahu K, Gale CM, Lifshits E, et al
    PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib.
    Cancer Res. 2007;67:11924-32.
    PubMed     Related articles    Abstract available
    
    
    
31. JIN Q , Feng L, Behrens C, Bekele BN, et al
    Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Cancer Res. 2007;67:11630-9.
    PubMed     Related articles    Abstract available
    
    
    
32. DENG J , Shimamura T, Perera S, Carlson NE, et al
    Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion.
    Cancer Res. 2007;67:11867-75.
    PubMed     Related articles    Abstract available
    
    
    
33. SHAREEF MM , Cui N, Burikhanov R, Gupta S, et al
    Role of tumor necrosis factor-alpha and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma.
    Cancer Res. 2007;67:11811-20.
    PubMed     Related articles    Abstract available
    
    
    
34. ISHIKAWA N , Takano A, Yasui W, Inai K, et al
    Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
    Cancer Res. 2007;67:11601-11.
    PubMed     Related articles    Abstract available
    
    
    
35. LEGRIER ME , Yang CP, Yan HG, Lopez-Barcons L, et al
    Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression.
    Cancer Res. 2007;67:11300-8.
    PubMed     Related articles    Abstract available
    
    
    
36. MOELLER M , Kershaw MH, Cameron R, Westwood JA, et al
    Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.
    Cancer Res. 2007;67:11428-37.
    PubMed     Related articles    Abstract available
    
    
    
37. LEE MS , Johansen L, Zhang Y, Wilson A, et al
    The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action.
    Cancer Res. 2007;67:11359-67.
    PubMed     Related articles    Abstract available
    
    
    
38. LI N , Zheng Y, Chen W, Wang C, et al
    Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis.
    Cancer Res. 2007;67:11176-85.
    PubMed     Related articles    Abstract available
    
    
    
39. WEIDHAAS JB , Babar I, Nallur SM, Trang P, et al
    MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.
    Cancer Res. 2007;67:11111-6.
    PubMed     Related articles    Abstract available
    
    
    November 2007
40. LEE TY , Lin CT, Kuo SY, Chang DK, et al
    Peptide-Mediated Targeting to Tumor Blood Vessels of Lung Cancer for Drug Delivery.
    Cancer Res. 2007;67:10958-10965.
    PubMed     Related articles    Abstract available
    
    
    
41. CHENG YW , Wu MF, Wang J, Yeh KT, et al
    Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 Inactivation.
    Cancer Res. 2007;67:10686-10693.
    PubMed     Related articles    Abstract available
    
    
    
42. NANNI P , Nicoletti G, Palladini A, Croci S, et al
    Antimetastatic activity of a preventive cancer vaccine.
    Cancer Res. 2007;67:11037-44.
    PubMed     Related articles    Abstract available
    
    
    
43. WANG J , Bhutani M, Pathak AK, Lang W, et al
    Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.
    Cancer Res. 2007;67:10647-52.
    PubMed     Related articles    Abstract available
    
    
    
44. MAH V , Seligson DB, Li A, Marquez DC, et al
    Aromatase Expression Predicts Survival in Women with Early-Stage Non Small Cell Lung Cancer.
    Cancer Res. 2007;67:10484-10490.
    PubMed     Related articles    Abstract available
    
    
    
45. YU Z , Boggon TJ, Kobayashi S, Jin C, et al
    Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies.
    Cancer Res. 2007;67:10417-10427.
    PubMed     Related articles    Abstract available
    
    
    
46. JAYACHANDRAN G , Sazaki JI, Nishizaki M, Xu K, et al
    Fragile Histidine Triad Mediated Tumor Suppression of Lung Cancer by Targeting Multiple Components of the Ras/Rho GTPase Molecular Switch.
    Cancer Res. 2007;67:10379-10388.
    PubMed     Related articles    Abstract available
    
    
    
47. CONNOR KM , Hempel N, Nelson KK, Dabiri G, et al
    Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells.
    Cancer Res. 2007;67:10260-7.
    PubMed     Related articles    Abstract available
    
    
    October 2007
48. BUNT SK , Yang L, Sinha P, Clements VK, et al
    Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
    Cancer Res. 2007;67:10019-26.
    PubMed     Related articles    Abstract available
    
    
    
49. TANG ZQ , Han LY, Lin HH, Cui J, et al
    Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation.
    Cancer Res. 2007;67:9996-10003.
    PubMed     Related articles    Abstract available
    
    
    
50. STATHOPOULOS GT , Kollintza A, Moschos C, Psallidas I, et al
    Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Cancer Res. 2007;67:9825-34.
    PubMed     Related articles    Abstract available
    
    
    
51. MONTEL V , Gaultier A, Lester RD, Campana WM, et al
    The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development.
    Cancer Res. 2007;67:9817-24.
    PubMed     Related articles    Abstract available
    
    
    
52. EHATA S , Hanyu A, Hayashi M, Aburatani H, et al
    Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.
    Cancer Res. 2007;67:9694-703.
    PubMed     Related articles    Abstract available
    
    
    
53. GAN PP , Pasquier E, Kavallaris M
    Class III {beta}-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non Small Cell Lung Cancer.
    Cancer Res. 2007;67:9356-63.
    PubMed     Related articles    Abstract available
    
    
    
54. PALIWAL S , Kovi RC, Nath B, Chen YW, et al
    The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.
    Cancer Res. 2007;67:9322-9.
    PubMed     Related articles    Abstract available
    
    
    
55. RITCHIE KJ , Henderson CJ, Wang XJ, Vassieva O, et al
    Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane.
    Cancer Res. 2007;67:9248-57.
    PubMed     Related articles    Abstract available
    
    
    
56. LOPEZ-RIOS F , Sanchez-Arago M, Garcia-Garcia E, Ortega AD, et al
    Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas.
    Cancer Res. 2007;67:9013-7.
    PubMed     Related articles    Abstract available
    
    
    September 2007
57. POTIRON VA , Sharma G, Nasarre P, Clarhaut JA, et al
    Semaphorin SEMA3F Affects Multiple Signaling Pathways in Lung Cancer Cells.
    Cancer Res. 2007;67:8708-15.
    PubMed     Related articles    Abstract available
    
    
    
58. LALLY BE , Geiger GA, Kridel S, Arcury-Quandt AE, et al
    Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library.
    Cancer Res. 2007;67:8791-9.
    PubMed     Related articles    Abstract available
    
    
    
59. LI Y , Du H, Qin Y, Roberts J, et al
    Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung.
    Cancer Res. 2007;67:8494-503.
    PubMed     Related articles    Abstract available
    
    
    
60. ARENA S , Isella C, Martini M, de Marco A, et al
    Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers.
    Cancer Res. 2007;67:8468-76.
    PubMed     Related articles    Abstract available
    
    
    
61. GORLOV IP , Meyer P, Liloglou T, Myles J, et al
    Seizure 6-Like (SEZ6L) Gene and Risk for Lung Cancer.
    Cancer Res. 2007;67:8406-11.
    PubMed     Related articles    Abstract available
    
    
    
62. MIZUKAMI M , Hanagiri T, Yasuda M, Kuroda K, et al
    Antitumor Effect of Antibody against a SEREX-Defined Antigen (UOEH-LC-1) on Lung Cancer Xenotransplanted into Severe Combined Immunodeficiency Mice.
    Cancer Res. 2007;67:8351-7.
    PubMed     Related articles    Abstract available
    
    
    
63. ZAGORSKI WA , Knudsen ES, Reed MF
    Retinoblastoma deficiency increases chemosensitivity in lung cancer.
    Cancer Res. 2007;67:8264-73.
    PubMed     Related articles    Abstract available
    
    
    
64. KISSIL JL , Walmsley MJ, Hanlon L, Haigis KM, et al
    Requirement for Rac1 in a K-ras Induced Lung Cancer in the Mouse.
    Cancer Res. 2007;67:8089-94.
    PubMed     Related articles    Abstract available
    
    
    
65. OHSHIRO K , Rayala SK, Kondo S, Gaur A, et al
    Identifying the estrogen receptor coactivator PELP1 in autophagosomes.
    Cancer Res. 2007;67:8164-71.
    PubMed     Related articles    Abstract available
    
    
    
66. DEEB KK , Michalowska AM, Yoon CY, Krummey SM, et al
    Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
    Cancer Res. 2007;67:8065-80.
    PubMed     Related articles    Abstract available
    
    
    
67. KONISHI J , Kawaguchi KS, Vo H, Haruki N, et al
    Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Cancer Res. 2007;67:8051-7.
    PubMed     Related articles    Abstract available
    
    
    
68. YUAN Y , Qin L, Liu D, Wu RC, et al
    Genetic Screening Reveals an Essential Role of p27kip1 in Restriction of Breast Cancer Progression.
    Cancer Res. 2007;67:8032-42.
    PubMed     Related articles    Abstract available
    
    
    
69. CHEN Y , De Marco MA, Graziani I, Gazdar AF, et al
    Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung.
    Cancer Res. 2007;67:7954-9.
    PubMed     Related articles    Abstract available
    
    
    August 2007
70. JOO JH , Liao G, Collins JB, Grissom SF, et al
    Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response.
    Cancer Res. 2007;67:7929-36.
    PubMed     Related articles    Abstract available
    
    
    
71. FAN T , Li R, Todd NW, Qiu Q, et al
    Up-regulation of 14-3-3{zeta} in Lung Cancer and Its Implication as Prognostic and Therapeutic Target.
    Cancer Res. 2007;67:7901-6.
    PubMed     Related articles    Abstract available
    
    
    
72. OGINO A , Kitao H, Hirano S, Uchida A, et al
    Emergence of Epidermal Growth Factor Receptor T790M Mutation during Chronic Exposure to Gefitinib in a Non Small Cell Lung Cancer Cell Line.
    Cancer Res. 2007;67:7807-14.
    PubMed     Related articles    Abstract available
    
    
    
73. CHANG MY , Boulden J, Katz JB, Wang L, et al
    Bin1 Ablation Increases Susceptibility to Cancer during Aging, Particularly Lung Cancer.
    Cancer Res. 2007;67:7605-12.
    PubMed     Related articles    Abstract available
    
    
    
74. WENG Y , Fang C, Turesky RJ, Behr M, et al
    Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice.
    Cancer Res. 2007;67:7825-32.
    PubMed     Related articles    Abstract available
    
    
    
75. ZHANG L , Hill RP
    Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion.
    Cancer Res. 2007;67:7789-97.
    PubMed     Related articles    Abstract available
    
    
    
76. YENDAMURI S , Trapasso F, Ferracin M, Cesari R, et al
    Tumor suppressor functions of ARLTS1 in lung cancers.
    Cancer Res. 2007;67:7738-45.
    PubMed     Related articles    Abstract available
    
    
    
77. PADRON D , Sato M, Shay JW, Gazdar AF, et al
    Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized.
    Cancer Res. 2007;67:7695-702.
    PubMed     Related articles    Abstract available
    
    
    
78. CHEN YW , Klimstra DS, Mongeau ME, Tatem JL, et al
    Loss of p53 and Ink4a/Arf Cooperate in a Cell Autonomous Fashion to Induce Metastasis of Hepatocellular Carcinoma Cells.
    Cancer Res. 2007;67:7589-96.
    PubMed     Related articles    Abstract available
    
    
    
79. GRANDIS JR , Carbone DP, Rustgi AK
    Advances and challenges in aerodigestive epithelial cancer: meeting summary and research opportunities.
    Cancer Res. 2007;67:7556-8.
    PubMed     Related articles   
    
    
    
80. KIM B , Lee HJ, Choi HY, Shin Y, et al
    Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Cancer Res. 2007;67:7431-8.
    PubMed     Related articles    Abstract available
    
    
    
81. LIAO CP , Zhong C, Saribekyan G, Bading J, et al
    Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
    Cancer Res. 2007;67:7525-33.
    PubMed     Related articles    Abstract available
    
    
    
82. YOON Y , Liang Z, Zhang X, Choe M, et al
    CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
    Cancer Res. 2007;67:7518-24.
    PubMed     Related articles    Abstract available
    
    
    
83. LI B , Allendorf DJ, Hansen R, Marroquin J, et al
    Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.
    Cancer Res. 2007;67:7421-30.
    PubMed     Related articles    Abstract available
    
    
    
84. AKLI S , Van Pelt CS, Bui T, Multani AS, et al
    Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Cancer Res. 2007;67:7212-22.
    PubMed     Related articles    Abstract available
    
    
    July 2007
85. SONG JH , Tse MC, Bellail A, Phuphanich S, et al
    Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
    Cancer Res. 2007;67:6946-55.
    PubMed     Related articles    Abstract available
    
    
    
86. MAJIDI M , Al-Wadei HA, Takahashi T, Schuller HM, et al
    Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells.
    Cancer Res. 2007;67:6863-71.
    PubMed     Related articles    Abstract available
    
    
    
87. LINARDIC CM , Naini S, Herndon JE 2nd, Kesserwan C, et al
    The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescence.
    Cancer Res. 2007;67:6691-9.
    PubMed     Related articles    Abstract available
    
    
    
88. JIANG JG , Ning YG, Chen C, Ma D, et al
    Cytochrome p450 epoxygenase promotes human cancer metastasis.
    Cancer Res. 2007;67:6665-74.
    PubMed     Related articles    Abstract available
    
    
    
89. PULUKURI SM , Rao JS
    Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis.
    Cancer Res. 2007;67:6637-46.
    PubMed     Related articles    Abstract available
    
    
    
90. MI L , Wang X, Govind S, Hood BL, et al
    The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells.
    Cancer Res. 2007;67:6409-16.
    PubMed     Related articles    Abstract available
    
    
    
91. LIU LZ , Zhou XD, Qian G, Shi X, et al
    AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
    Cancer Res. 2007;67:6325-32.
    PubMed     Related articles    Abstract available
    
    
    
92. OHTANI S , Iwamaru A, Deng W, Ueda K, et al
    Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.
    Cancer Res. 2007;67:6293-303.
    PubMed     Related articles    Abstract available
    
    
    
93. DE LA MOTTE ROUGE T , Galluzzi L, Olaussen KA, Zermati Y, et al
    A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib.
    Cancer Res. 2007;67:6253-62.
    PubMed     Related articles    Abstract available
    
    
    
94. BAE KM , Wang H, Jiang G, Chen MG, et al
    Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner.
    Cancer Res. 2007;67:6053-63.
    PubMed     Related articles    Abstract available
    
    
    
95. KASSIE F , Anderson LB, Scherber R, Yu N, et al
    Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels.
    Cancer Res. 2007;67:6502-11.
    PubMed     Related articles    Abstract available
    
    
    
96. WU M , Min C, Wang X, Yu Z, et al
    Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
    Cancer Res. 2007;67:6278-85.
    PubMed     Related articles    Abstract available
    
    
    
97. ADISESHAIAH P , Lindner DJ, Kalvakolanu DV, Reddy SP, et al
    FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo.
    Cancer Res. 2007;67:6204-11.
    PubMed     Related articles    Abstract available
    
    
    
98. TANAKA H , Yanagisawa K, Shinjo K, Taguchi A, et al
    Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.
    Cancer Res. 2007;67:6007-11.
    PubMed     Related articles    Abstract available
    
    
    June 2007
99. ENGELS EA , Wu X, Gu J, Dong Q, et al
    Systematic Evaluation of Genetic Variants in the Inflammation Pathway and Risk of Lung Cancer.
    Cancer Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
100. STRUYF S , Burdick MD, Peeters E, Van den Broeck K, et al
     Platelet Factor-4 Variant Chemokine CXCL4L1 Inhibits Melanoma and Lung Carcinoma Growth and Metastasis by Preventing Angiogenesis.
     Cancer Res. 2007;67:5940-8.
     PubMed     Related articles    Abstract available
     
     
     
101. ELAYADI AN , Samli KN, Prudkin L, Liu YH, et al
     A Peptide Selected by Biopanning Identifies the Integrin {alpha}v{beta}6 as a Prognostic Biomarker for Nonsmall Cell Lung Cancer.
     Cancer Res. 2007;67:5889-5895.
     PubMed     Related articles    Abstract available
     
     
     
102. YANG L , Amann JM, Kikuchi T, Porta R, et al
     Inhibition of Epidermal Growth Factor Receptor Signaling Elevates 15-Hydroxyprostaglandin Dehydrogenase in Non-Small-Cell Lung Cancer.
     Cancer Res. 2007;67:5587-5593.
     PubMed     Related articles    Abstract available
     
     
     
103. LIANG S , Sharma A, Peng HH, Robertson G, et al
     Targeting Mutant (V600E) B-Raf in Melanoma Interrupts Immunoediting of Leukocyte Functions and Melanoma Extravasation.
     Cancer Res. 2007;67:5814-20.
     PubMed     Related articles    Abstract available
     
     
     
104. CHALLITA-EID PM , Morrison K, Etessami S, An Z, et al
     Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.
     Cancer Res. 2007;67:5798-805.
     PubMed     Related articles    Abstract available
     
     
     
105. MOUNAWAR M , Mukeria A, Le Calvez F, Hung RJ, et al
     Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
     Cancer Res. 2007;67:5667-72.
     PubMed     Related articles    Abstract available
     
     
     
106. WITTNEBEL S , Da Rocha S, Giron-Michel J, Jalil A, et al
     Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
     Cancer Res. 2007;67:5594-9.
     PubMed     Related articles    Abstract available
     
     
     
107. DAS AK , Chen BP, Story MD, Sato M, et al
     Somatic Mutations in the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor (EGFR) Abrogate EGFR-Mediated Radioprotection in Non-Small Cell Lung Carcinoma.
     Cancer Res. 2007;67:5267-74.
     PubMed     Related articles    Abstract available
     
     
     
108. SAVAI R , Schermuly RT, Pullamsetti SS, Schneider M, et al
     A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells.
     Cancer Res. 2007;67:5443-53.
     PubMed     Related articles    Abstract available
     
     
     
109. KOZIN SV , Winkler F, Garkavtsev I, Hicklin DJ, et al
     Human tumor xenografts recurring after radiotherapy are more sensitive to anti-vascular endothelial growth factor receptor-2 treatment than treatment-naive tumors.
     Cancer Res. 2007;67:5076-82.
     PubMed     Related articles    Abstract available
     
     
     May 2007
110. QIU Y , Liu X, Zou W, Yue P, et al
     The Farnesyltransferase Inhibitor R115777 Up-regulates the Expression of Death Receptor 5 and Enhances TRAIL-Induced Apoptosis in Human Lung Cancer Cells.
     Cancer Res. 2007;67:4973-80.
     PubMed     Related articles    Abstract available
     
     
     
111. JI H , Wang Z, Perera SA, Li D, et al
     Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models.
     Cancer Res. 2007;67:4933-9.
     PubMed     Related articles    Abstract available
     
     
     
112. HO MM , Ng AV, Lam S, Hung JY, et al
     Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells.
     Cancer Res. 2007;67:4827-33.
     PubMed     Related articles    Abstract available
     
     
     
113. VIKIS H , Sato M, James M, Wang D, et al
     EGFR-T790M Is a Rare Lung Cancer Susceptibility Allele with Enhanced Kinase Activity.
     Cancer Res. 2007;67:4665-70.
     PubMed     Related articles    Abstract available
     
     
     
114. LAM DC , Girard L, Ramirez R, Chau WS, et al
     Expression of Nicotinic Acetylcholine Receptor Subunit Genes in Non-Small-Cell Lung Cancer Reveals Differences between Smokers and Nonsmokers.
     Cancer Res. 2007;67:4638-47.
     PubMed     Related articles    Abstract available
     
     
     
115. PADERA TP , Ancukiewicz M, Hoshida T, Fukumura D, et al
     Data do not support benefits of anti-VEGFR3 therapy.
     Cancer Res. 2007;67:5055.
     PubMed     Related articles   
     
     
     
116. LIU X , Yue P, Chen S, Hu L, et al
     The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
     Cancer Res. 2007;67:4981-8.
     PubMed     Related articles    Abstract available
     
     
     
117. OH HK , Ha JM, O E, Lee BH, et al
     Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
     Cancer Res. 2007;67:4851-9.
     PubMed     Related articles    Abstract available
     
     
     
118. WANG CC , Tsai MF, Dai TH, Hong TM, et al
     Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.
     Cancer Res. 2007;67:4816-26.
     PubMed     Related articles    Abstract available
     
     
     
119. TOOKER P , Yen WC, Ng SC, Negro-Vilar A, et al
     Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification.
     Cancer Res. 2007;67:4425-33.
     PubMed     Related articles    Abstract available
     
     
     
120. SINGHAL SS , Singhal J, Yadav S, Dwivedi S, et al
     Regression of Lung and Colon Cancer Xenografts by Depleting or Inhibiting RLIP76 (Ral-Binding Protein 1).
     Cancer Res. 2007;67:4382-9.
     PubMed     Related articles    Abstract available
     
     
     
121. FUNASAKA T , Hu H, Yanagawa T, Hogan V, et al
     Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
     Cancer Res. 2007;67:4236-43.
     PubMed     Related articles    Abstract available
     
     
     
122. LING X , Konopleva M, Zeng Z, Ruvolo V, et al
     The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.
     Cancer Res. 2007;67:4210-8.
     PubMed     Related articles    Abstract available
     
     
     
123. HAYAMA S , Daigo Y, Yamabuki T, Hirata D, et al
     Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis.
     Cancer Res. 2007;67:4113-22.
     PubMed     Related articles    Abstract available
     
     
     April 2007
124. SONG P , Sekhon HS, Lu A, Arredondo J, et al
     M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
     Cancer Res. 2007;67:3936-44.
     PubMed     Related articles    Abstract available
     
     
     
125. PURI N , Khramtsov A, Ahmed S, Nallasura V, et al
     A Selective Small Molecule Inhibitor of c-Met, PHA665752, Inhibits Tumorigenicity and Angiogenesis in Mouse Lung Cancer Xenografts.
     Cancer Res. 2007;67:3529-34.
     PubMed     Related articles    Abstract available
     
     
     
126. LAY JD , Hong CC, Huang JS, Yang YY, et al
     Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL.
     Cancer Res. 2007;67:3878-87.
     PubMed     Related articles    Abstract available
     
     
     
127. CHEN G , Wang X, Yu J, Varambally S, et al
     Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
     Cancer Res. 2007;67:3461-7.
     PubMed     Related articles    Abstract available
     
     
     
128. ZIPIN-ROITMAN A , Meshel T, Sagi-Assif O, Shalmon B, et al
     CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
     Cancer Res. 2007;67:3396-405.
     PubMed     Related articles    Abstract available
     
     
     
129. SU Y , Ortiz J, Liu S, Bugge TH, et al
     Systematic urokinase-activated anthrax toxin therapy produces regressions of subcutaneous human non-small cell lung tumor in athymic nude mice.
     Cancer Res. 2007;67:3329-36.
     PubMed     Related articles    Abstract available
     
     
     
130. YANG D , Thangaraju M, Greeneltch K, Browning DD, et al
     Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells.
     Cancer Res. 2007;67:3301-9.
     PubMed     Related articles    Abstract available
     
     
     
131. PEI XH , Bai F, Smith MD, Xiong Y, et al
     p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers.
     Cancer Res. 2007;67:3162-70.
     PubMed     Related articles    Abstract available
     
     
     
132. HULIT J , Suyama K, Chung S, Keren R, et al
     N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
     Cancer Res. 2007;67:3106-16.
     PubMed     Related articles    Abstract available
     
     
     
133. KHAN N , Afaq F, Kweon MH, Kim K, et al
     Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.
     Cancer Res. 2007;67:3475-82.
     PubMed     Related articles    Abstract available
     
     
     March 2007
134. LIBY K , Royce DB, Williams CR, Risingsong R, et al
     The Synthetic Triterpenoids CDDO-Methyl Ester and CDDO-Ethyl Amide Prevent Lung Cancer Induced by Vinyl Carbamate in A/J Mice.
     Cancer Res. 2007;67:2414-9.
     PubMed     Related articles    Abstract available
     
     
     
135. MENON J , Soto-Pantoja DR, Callahan MF, Cline JM, et al
     Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.
     Cancer Res. 2007;67:2809-15.
     PubMed     Related articles    Abstract available
     
     
     
136. YAMABUKI T , Takano A, Hayama S, Ishikawa N, et al
     Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas.
     Cancer Res. 2007;67:2517-25.
     PubMed     Related articles    Abstract available
     
     
     
137. WANG M , Zhang Z, Zhang Z, Vikis H, et al
     Fine mapping and candidate gene analyses of pulmonary adenoma resistance 1, a major genetic determinant of mouse lung adenoma resistance.
     Cancer Res. 2007;67:2508-16.
     PubMed     Related articles    Abstract available
     
     
     
138. WEISZ L , Damalas A, Liontos M, Karakaidos P, et al
     Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells.
     Cancer Res. 2007;67:2396-401.
     PubMed     Related articles    Abstract available
     
     
     
139. LUTTERBACH B , Zeng Q, Davis LJ, Hatch H, et al
     Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival.
     Cancer Res. 2007;67:2081-8.
     PubMed     Related articles    Abstract available
     
     
     
140. OKABE T , Okamoto I, Tamura K, Terashima M, et al
     Differential Constitutive Activation of the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cells Bearing EGFR Gene Mutation and Amplification.
     Cancer Res. 2007;67:2046-53.
     PubMed     Related articles    Abstract available
     
     
     
141. CHIOSEA S , Jelezcova E, Chandran U, Luo J, et al
     Overexpression of Dicer in precursor lesions of lung adenocarcinoma.
     Cancer Res. 2007;67:2345-50.
     PubMed     Related articles    Abstract available
     
     
     
142. MULLOY R , Ferrand A, Kim Y, Sordella R, et al
     Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib.
     Cancer Res. 2007;67:2325-30.
     PubMed     Related articles    Abstract available
     
     
     
143. PROVINCIALI M , Papalini F, Orlando F, Pierpaoli S, et al
     Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
     Cancer Res. 2007;67:2022-9.
     PubMed     Related articles    Abstract available
     
     
     
144. D'ARMIENTO J , Imai K, Schiltz J, Kolesnekova N, et al
     Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis.
     Cancer Res. 2007;67:1902-9.
     PubMed     Related articles    Abstract available
     
     
     February 2007
145. TAKEDA T , Hattori N, Tokuhara T, Nishimura Y, et al
     Adenoviral Transduction of MRP-1/CD9 and KAI1/CD82 Inhibits Lymph Node Metastasis in Orthotopic Lung Cancer Model.
     Cancer Res. 2007;67:1744-9.
     PubMed     Related articles    Abstract available
     
     
     
146. BRUECKNER B , Stresemann C, Kuner R, Mund C, et al
     The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
     Cancer Res. 2007;67:1419-23.
     PubMed     Related articles    Abstract available
     
     
     
147. TAHIR SK , Yang X, Anderson MG, Morgan-Lappe SE, et al
     Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737.
     Cancer Res. 2007;67:1176-83.
     PubMed     Related articles    Abstract available
     
     
     
148. RHO JK , Choi YJ, Ryoo BY, Na II, et al
     p53 Enhances Gefitinib-Induced Growth Inhibition and Apoptosis by Regulation of Fas in Non-Small Cell Lung Cancer.
     Cancer Res. 2007;67:1163-9.
     PubMed     Related articles    Abstract available
     
     
     
149. SCHAEFER G , Shao L, Totpal K, Akita RW, et al
     Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression.
     Cancer Res. 2007;67:1228-38.
     PubMed     Related articles    Abstract available
     
     
     
150. JACKSON SR , Zhu CH, Paulson V, Watkins L, et al
     Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.
     Cancer Res. 2007;67:1121-9.
     PubMed     Related articles    Abstract available
     
     
     January 2007
151. DENG WG , Kawashima H, Wu G, Jayachandran G, et al
     Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cel
     Cancer Res. 2007;67:709-17.
     PubMed     Related articles    Abstract available
     
     
     
152. ACHIWA H , Lazo JS
     PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
     Cancer Res. 2007;67:643-50.
     PubMed     Related articles    Abstract available
     
     
     
153. LIAO D , Corle C, Seagroves TN, Johnson RS, et al
     Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.
     Cancer Res. 2007;67:563-72.
     PubMed     Related articles    Abstract available
     
     
     
154. ZINN RL , Pruitt K, Eguchi S, Baylin SB, et al
     hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
     Cancer Res. 2007;67:194-201.
     PubMed     Related articles    Abstract available
     
     
     
155. WANG M , Vikis HG, Wang Y, Jia D, et al
     Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1.
     Cancer Res. 2007;67:93-9.
     PubMed     Related articles    Abstract available
     
     
     December 2006
156. GHOSH AK , Steele R, Ryerse J, Ray RB, et al
     Tumor-Suppressive Effects of MBP-1 in Non-Small Cell Lung Cancer Cells.
     Cancer Res. 2006;66:11907-12.
     PubMed     Related articles    Abstract available
     
     
     
157. SHER YP , Chou CC, Chou RH, Wu HM, et al
     Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness.
     Cancer Res. 2006;66:11763-70.
     PubMed     Related articles    Abstract available
     
     
     
158. SHI J , Liu Y, Zheng Y, Guo Y, et al
     Therapeutic expression of an anti-death receptor 5 single-chain fixed-variable region prevents tumor growth in mice.
     Cancer Res. 2006;66:11946-53.
     PubMed     Related articles    Abstract available
     
     
     
159. MORGAN MT , Nakanishi Y, Kroll DJ, Griset AP, et al
     Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro.
     Cancer Res. 2006;66:11913-21.
     PubMed     Related articles    Abstract available
     
     
     
160. CAO C , Albert JM, Geng L, Ivy PS, et al
     Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor AZD2171 and Fractionated Radiotherapy in Mouse Models of Lung Cancer.
     Cancer Res. 2006;66:11409-15.
     PubMed     Related articles    Abstract available
     
     
     
161. GENG L , Cuneo KC, Fu A, Tu T, et al
     Histone Deacetylase (HDAC) Inhibitor LBH589 Increases Duration of {gamma}-H2AX Foci and Confines HDAC4 to the Cytoplasm in Irradiated Non-Small Cell Lung Cancer.
     Cancer Res. 2006;66:11298-304.
     PubMed     Related articles    Abstract available
     
     
     
162. LIU X , Yue P, Schonthal AH, Khuri FR, et al
     Cellular FLICE-Inhibitory Protein Down-regulation Contributes to Celecoxib-Induced Apoptosis in Human Lung Cancer Cells.
     Cancer Res. 2006;66:11115-9.
     PubMed     Related articles    Abstract available
     
     
     
163. LU G , Liao J, Yang G, Reuhl KR, et al
     Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine.
     Cancer Res. 2006;66:11494-501.
     PubMed     Related articles    Abstract available
     
     
     
164. KOBAYASHI S , Shimamura T, Monti S, Steidl U, et al
     Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.
     Cancer Res. 2006;66:11389-98.
     PubMed     Related articles    Abstract available
     
     
     
165. CHEN X , Lin J, Kanekura T, Su J, et al
     A Small Interfering CD147-Targeting RNA Inhibited the Proliferation, Invasiveness, and Metastatic Activity of Malignant Melanoma.
     Cancer Res. 2006;66:11323-30.
     PubMed     Related articles    Abstract available
     
     
     
166. SHEN J , Behrens C, Wistuba II, Feng L, et al
     Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.
     Cancer Res. 2006;66:11194-206.
     PubMed     Related articles    Abstract available
     
     
     November 2006
167. LANDI S , Gemignani F, Canzian F, Gaborieau V, et al
     DNA Repair and Cell Cycle Control Genes and the Risk of Young-Onset Lung Cancer.
     Cancer Res. 2006;66:11062-11069.
     PubMed     Related articles    Abstract available
     
     
     
168. EHRICH M , Field JK, Liloglou T, Xinarianos G, et al
     Cytosine Methylation Profiles as a Molecular Marker in Non-Small Cell Lung Cancer.
     Cancer Res. 2006;66:10911-10918.
     PubMed     Related articles    Abstract available
     
     
     
169. LIM JH , Park JW, Chun YS
     Human Arrest Defective 1 Acetylates and Activates {beta}-Catenin, Promoting Lung Cancer Cell Proliferation.
     Cancer Res. 2006;66:10677-10682.
     PubMed     Related articles    Abstract available
     
     
     
170. ANUMANTHAN G , Halder SK, Friedman DB, Datta PK, et al
     Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism.
     Cancer Res. 2006;66:10824-32.
     PubMed     Related articles    Abstract available
     
     
     
171. MARSIT CJ , Houseman EA, Christensen BC, Eddy K, et al
     Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors.
     Cancer Res. 2006;66:10621-9.
     PubMed     Related articles    Abstract available
     
     
     
172. CHAUDHRY UI , Kingham TP, Plitas G, Katz SC, et al
     Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth.
     Cancer Res. 2006;66:10497-504.
     PubMed     Related articles    Abstract available
     
     
     
173. TIAN J , Mahmood R, Hnasko R, Locker J, et al
     Loss of Nkx2.8 deregulates progenitor cells in the large airways and leads to dysplasia.
     Cancer Res. 2006;66:10399-407.
     PubMed     Related articles    Abstract available
     
     
     
174. HAYAMA S , Daigo Y, Kato T, Ishikawa N, et al
     Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis.
     Cancer Res. 2006;66:10339-48.
     PubMed     Related articles    Abstract available
     
     
     October 2006
175. MORGILLO F , Woo JK, Kim ES, Hong WK, et al
     Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.
     Cancer Res. 2006;66:10100-11.
     PubMed     Related articles    Abstract available
     
     
     
176. PASTORINO F , Brignole C, Di Paolo D, Nico B, et al
     Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
     Cancer Res. 2006;66:10073-82.
     PubMed     Related articles    Abstract available
     
     
     
177. KOIZUMI F , Kitagawa M, Negishi T, Onda T, et al
     Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors.
     Cancer Res. 2006;66:10048-56.
     PubMed     Related articles    Abstract available
     
     
     
178. UEDA K , Kawashima H, Ohtani S, Deng WG, et al
     The 3p21.3 Tumor Suppressor NPRL2 Plays an Important Role in Cisplatin-Induced Resistance in Human Non-Small-Cell Lung Cancer Cells.
     Cancer Res. 2006;66:9682-90.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
179. SAITO Y , Tachibana I, Takeda Y, Yamane H, et al
     Absence of CD9 Enhances Adhesion-Dependent Morphologic Differentiation, Survival, and Matrix Metalloproteinase-2 Production in Small Cell Lung Cancer Cells.
     Cancer Res. 2006;66:9557-65.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
180. TAKAHASHI K , Furukawa C, Takano A, Ishikawa N, et al
     The neuromedin u-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.
     Cancer Res. 2006;66:9408-19.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     September 2006
181. CAI D , Latham VM Jr, Zhang X, Shapiro GI, et al
     Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells.
     Cancer Res. 2006;66:9270-80.
     PubMed     Related articles    Abstract available
     
     
     
182. PORE N , Gupta AK, Cerniglia GJ, Jiang Z, et al
     Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.
     Cancer Res. 2006;66:9252-9.
     PubMed     Related articles    Abstract available
     
     
     
183. CHEN H , Yan Y, Davidson TL, Shinkai Y, et al
     Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells.
     Cancer Res. 2006;66:9009-16.
     PubMed     Related articles    Abstract available
     
     
     August 2006
184. SHARMA A , Tran MA, Liang S, Sharma AK, et al
     Targeting Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase in the Mutant (V600E) B-Raf Signaling Cascade Effectively Inhibits Melanoma Lung Metastases.
     Cancer Res. 2006;66:8200-9.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
185. WALSER TC , Rifat S, Ma X, Kundu N, et al
     Antagonism of CXCR3 Inhibits Lung Metastasis in a Murine Model of Metastatic Breast Cancer.
     Cancer Res. 2006;66:7701-7.
     PubMed     Related articles    Abstract available
     
     
     
186. RAPONI M , Zhang Y, Yu J, Chen G, et al
     Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
     Cancer Res. 2006;66:7466-72.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: